Metabolic Biomarkers in Diabetes

Metabolic biomarkers are essential tools for diagnosing and monitoring diabetes. Key biomarkers include fasting blood glucose, hemoglobin A1c (HbA1c), and insulin levels, which provide insight into glycemic control and insulin resistance. Additionally, emerging biomarkers such as lipid profiles, inflammatory markers, and gut-derived metabolites are being explored for their roles in diabetes pathophysiology. These biomarkers can help in stratifying risk, guiding treatment decisions, and monitoring disease progression. Ongoing research is focused on identifying novel biomarkers that could further enhance our understanding of diabetes and improve management strategies for individuals at risk or living with the disease.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp